Jun activation domain-binding protein 1 negatively regulate p27kip1 in non-Hodgkin’s lymphomas

Abstract

These findings suggest that Jab1 protein may contribute to the tumor progression through Jab1-mediated p27kip1 degradation and that control of Jab1 expression is a novel therapeutic target with NHLs.